A new study reveals impaired insulin signaling in the brain negatively affects cognition, memory and learning. The findings shed light on why those with type 2 diabetes are at greater risk of developing Alzheimer’s disease.
Source: Joslin Diabetes Center.
Scientists continue to find evidence linking Type 2 diabetes with Alzheimer’s disease, the most common form of dementia and the seventh leading cause of death in the United States. However, little is understood about the mechanism by which the two are connected.
Now, researchers at Joslin Diabetes Center, an affiliate of Harvard Medical School, have demonstrated that impaired insulin signaling in the brain negatively affects cognition, mood and metabolism, all components of Alzheimer’s Disease.
Read full article: https://neurosciencenews.com/insulin-alzheimers-10720/
